当前位置:
X-MOL 学术
›
Cancer Biol. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia
Cancer Biology & Therapy ( IF 3.6 ) Pub Date : 2023-11-14 , DOI: 10.1080/15384047.2023.2278229 Shuxin Huang 1 , Yujie Zhao 1 , Wenpu Lai 1 , Jiaxiong Tan 1 , Xue Zheng 2 , Xianfeng Zha 3 , Yangqiu Li 1 , Shaohua Chen 1
Cancer Biology & Therapy ( IF 3.6 ) Pub Date : 2023-11-14 , DOI: 10.1080/15384047.2023.2278229 Shuxin Huang 1 , Yujie Zhao 1 , Wenpu Lai 1 , Jiaxiong Tan 1 , Xue Zheng 2 , Xianfeng Zha 3 , Yangqiu Li 1 , Shaohua Chen 1
Affiliation
With the success of immune checkpoint inhibitors (ICI), such as anti- programmed death-1 (PD-1) antibody for solid tumors and lymphoma immunotherapy, a number of clinical trials with ICIs have been...
中文翻译:
IFN-γ+ T 细胞上较高的 PD-1/Tim-3 表达与急性髓系白血病患者的不良预后相关
随着免疫检查点抑制剂 (ICI) 的成功,例如用于实体瘤和淋巴瘤免疫治疗的抗程序性死亡 1 (PD-1) 抗体,许多 ICI 的临床试验已经...
更新日期:2023-11-18
中文翻译:
IFN-γ+ T 细胞上较高的 PD-1/Tim-3 表达与急性髓系白血病患者的不良预后相关
随着免疫检查点抑制剂 (ICI) 的成功,例如用于实体瘤和淋巴瘤免疫治疗的抗程序性死亡 1 (PD-1) 抗体,许多 ICI 的临床试验已经...